semaglutide off shortage list The GLP-1 drug is over. What's next for the compounders? FDA's GLP-1 decision kicks off

Targeting tissue-resident memory CD8 + T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis

Prime/MRx is committed to using our real-world research to help our clients make informed benefit decisions for GLP-1 coverage as they navigate this dynamic landscape. For additional information and study design details, please refer to the year-two abstract

In a cross-sectional study of the association between hyperuricaemia, hypertension and ischemic stroke, higher risk is found even after full adjustment in participants with hyperuricaemia and hypertension (Sun et al., 2021)

Who Should Consider It Worth the Price

Alabama, the District of Columbia, and Michigan on October 1

Trimethylamine N-oxide mediated Y-box binding protein-1 nuclear translocation promotes cell cycle progression by directly downregulating Gadd45a expression in a cellular model of chronic kidney disease